CHINA HEALTH GRP HD-10 (VNL1) — Capital Reinvestment Ratio
Latest as of December 2024:
0.17x
CHINA HEALTH GRP HD-10 (VNL1) has a Capital Reinvestment Ratio of 0.17x as of December 2024, meaning it reinvests 0% of its operating cash flow (€10.28 Million) in capital expenditures (€1.76 Million). See cash generation quality of CHINA HEALTH GRP HD-10 to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.17x
Capex / Operating Cash Flow
Operating Cash Flow
€10.28 Million
EUR
Capital Expenditures
€1.76 Million
EUR
Data as of
Dec 2024
Most recent filing
CHINA HEALTH GRP HD-10 Capital Reinvestment Ratio (2023–2024)
This chart tracks CHINA HEALTH GRP HD-10's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for CHINA HEALTH GRP HD-10 (2023–2024)
Year-by-year Capital Reinvestment Ratio for CHINA HEALTH GRP HD-10 from 2023 to 2024. For live market cap and broader valuation context, see VNL1 market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.17x | €10.28 Million | €1.76 Million | ▼ -96.8% |
| 2023 | 5.36x | €1.12 Million | €6.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow